Research progress in CAR-T immunotherapy for antiviral infections
At present,most viral infections in the world have no miracle drugs,especially viruses with latent infection ability,such as hepatitis B virus(HBV),cytomegalovirus(CMV),Epstein-Barr virus(EBV),human immunodeficiency virus(HIV),etc.,which seriously threaten human health.After infecting host cells,these viruses interact with host proteins,causing host cells to express some specific infectious or latent marker proteins on cell surface,which can become targets of CAR-T therapy,providing a new direction for the cure of refractory viral diseases.
NETL
NSTL
万方数据
维普
